This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Mark Your Calendar for BPI Europe 2024!
9-12 April 2024Messe Wien Congress Centre, Vienna
Register by 1st Dec Save £900
Menu
Book
keyboard_arrow_right

Pre Conference Symposiums and Workshops - CET/CEST (Cent Europe Summer, GMT+2)

keyboard_arrow_leftSearch & Filter
search

Pre Conference Symposiums and Workshops - CET/CEST (Cent Europe Summer, GMT+2)

search
08:00 - 09:00
Coffee and Registration
Showing 4 of 4 Streams
09:00 - 09:30
Novel Approaches to Template-DNA Production
  • Innovations in DNA template preparation for use in synthesis during the production process
  • Enabling more effective RNA synthesis during the development process
  • Enhancing Plasmid DNA Manufacturing and approaches to employ across RNA-based therapeutics.
  • Movement towards an enzymatically focussed process, cell-free format
09:30 - 10:00
Next generation mRNA vaccine and therapeutics production aided by Quality by Design
  • Mabrouka Maamra - Project Manager, University of Sheffield
10:00 - 10:30
Development of a polycistronic expression platform for testing RNA-based therapeutics
  • Silvia Lecci, PhD - Team Leader, CPI
10:30 - 11:00
Scientific Track Presentation
09:00 - 09:30
Novel Strategies for the Rapid Discovery, Design and Continuous Manufacture of Biologics-Based Drug Products
  • Harris Makatsoris - Academics Professor of Sustainable Manufacturing Systems, King's College London
09:30 - 10:00
Strategy for the Development of Perfusion Process
  • Veronique Chotteau, PhD - Professor in mammalian-based bioprocessing, KTH - Royal Institute of Technology
10:00 - 10:30
Intensified Design of Experiments: A Lean Approach to Accelerate Upstream Process Characterization
  • Mark Duerkop - Chief Executive Officer, Novasign
10:30 - 11:00
Scientific Track Presentation
09:00 - 11:00
Tech Transfer

•Introduction to Tech Transfer

•Definition of TT

•Tech transfer: a Project with Challenges

• Session 1 : Formal Aspects

•Regulatory concerns ; product comparability

•Tech Transfer Procedure, Protocol & Report

  • Thomas Chattaway - Senior Life Science Consultant, Independent
09:00 - 11:00
This workshop will explore the current initiatives, innovative strategies and new technologies to designed to drive sustainability of biologics process development and manufacturing.
  • James Dean Vogel - Founder and Director , The BioProcess Institute
11:00 - 11:30
Morning Coffee Break
Showing 3 of 3 Streams
11:30 - 12:00
Developments in RNA Characterisation: Novel Approaches supporting RNA Manufacturing
  • Advancements and new technologies improving specificity for RNA-based therapeutic analysis, overcoming drawbacks of current analytical assays
  • Case study of Novel approaches to product analysis
  • Physicochemical analytics vs. cell-based assays
  • Improved analysis of sub-populations and heterogeneity
  • How can analytical techniques support the manufacturing of RNA-based therapeutics or vaccines?
12:00 - 12:30
mRNA-LNP: Navigating a complex manufacturing process
12:30 - 13:00
Scientific Track Presentation
11:30 - 12:00
An End-to-End Continuous Process for Monoclonal Antibody Production
  • Joseph Zeguer - Senior Scientist - Synthetic and Mammalian Upstream, CPI
12:00 - 12:30
On-line Monitoring and Control in Continuous Processes
  • Alois Jungbauer - Professor, Dept. of Biotechnology, University of Natural Resources and Applied Life Sciences
12:30 - 13:00
Scientific Track Presentation
11:30 - 13:00
Tech Transfer

•Session 2: Tools for Tech Transfer

•Transfer of Information

•Dealing with Scale up and changes

•Analytical Transfer

  • Thomas Chattaway - Senior Life Science Consultant, Independent
13:00 - 14:00
Lunch Break
Showing 3 of 3 Streams
14:00 - 14:30
Purification of RNA Product Downstream for reduction of dsRNA
  • Low levels of dsRNA impurities have been reported in some mRNA vaccines, known to potentially induce immune reactions
  • Downstream approaches to purify RNA product and reduce dsRNA impurities
  • Case study examples & data
14:30 - 15:00
Optimising the purification of RNA therapeutics
14:00 - 14:30
Advancing Clinical Manufacturing Through PAT Tools for Biologics
  • Michael Olma - Supervisor GMP Advanced Analytics, MSD
14:30 - 15:00
Digital Biomanufacturing for Accelerated, Sustainable Process Development and Distribution
  • Maria Papathanasiou - Senior Lecturer (Associate Professor), Imperial College London
14:00 - 15:00
Tech Transfer

•Session 3 : Complexities of Tech Transfer

•Complexity and Risk Factors

•The importance of communication

•Optimising the transfer programme

15:00 - 15:30
Afternoon Break
Showing 3 of 3 Streams
15:30 - 16:00
High-Throughput Sequencing for Quality Control
  • Utilising high-throughput sequencing to enhance the quality control of RNA product.
  • Increasing efficiency in workflow
16:00 - 16:30
EMA & Beyond: Regulatory Perspectives and GMP Considerations for the RNA Field
15:30 - 16:00
Optimizing Biologics Downstream Processing: Enhancing Sustainability and Productivity with an Intensification Toolbox
  • Matthias Hecht - Post Doc Downstream Bioprocess Development, Boehringer Ingelheim
16:00 - 16:30
Continuous Integrated Downstream Processing for Cell and Gene Therapy
  • Manuel Carrondo - Vice-President, Instituto de Biologia Experimental e Tecnológica
15:30 - 16:30
Tech Transfer

•Workshop: Tech Transfer in the life -cycle

16:30 - 16:35
End of Pre-Conference
NextDay One
Filter
Streams
Choose Day